Robert John Mentz
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in
-
- Heart Failure Treatment and Management 301
- Cardiovascular Function and Risk Factors 113
- Cardiac pacing and defibrillation studies 52
-
- Diabetes Treatment and Management 63
- Co-authors
- Christopher M. O’Connor (125 shared papers)Adrian F. Hernandez (146 shared papers)Gary Michael Felker (56 shared papers)Mona Fiuzat (61 shared papers)Stephen John Greene (103 shared papers)Adam D DeVore (74 shared papers)Aldo Pietro Maggioni (25 shared papers)Rury R. Holman (32 shared papers)
- Journals
- Journal of Cardiac Failure (113 papers)American Heart Journal (62 papers)European Journal of Heart Failure (59 papers)Journal of the American College of Cardiology (56 papers)JACC Heart Failure (55 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert John Mentz
639 papers receiving 22.6k citations
Robert John Mentz's Hit Papers
Peers
Comparison fields: 5 of 162
- Cardiology and Cardiovascular Medicine 11.0k
- Endocrinology, Diabetes and Metabolism 5.4k
- Geriatrics and Gerontology 497
- Nephrology 698
- Complementary and alternative medicine 645
Countries citing papers authored by Robert John Mentz
This map shows the geographic impact of Robert John Mentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert John Mentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert John Mentz more than expected).
Fields of papers citing papers by Robert John Mentz
This network shows the impact of papers produced by Robert John Mentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert John Mentz. The network helps show where Robert John Mentz may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert John Mentz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 682 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes Hit paper breakdown → | 2017 | 1706 |
| 2 | 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Hit paper breakdown → | 2023 | 1412 |
| 3 | The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial Hit paper breakdown → | 2022 | 670 |
| 4 | Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis Hit paper breakdown → | 2017 | 482 |
| 5 | Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update Hit paper breakdown → | 2019 | 460 |
| 6 | Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction Hit paper breakdown → | 2014 | 458 |
| 7 | Palliative Care in Heart Failure Hit paper breakdown → | 2017 | 455 |
| 8 | Physical Rehabilitation for Older Patients Hospitalized for Heart Failure Hit paper breakdown → | 2021 | 418 |
| 9 | Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction Hit paper breakdown → | 2019 | 342 |
| 10 | 2015 | 306 | |
| 11 | 2015 | 279 | |
| 12 | Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality Hit paper breakdown → | 2019 | 262 |
| 13 | 2017 | 249 | |
| 14 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial Hit paper breakdown → | 2019 | 239 |
| 15 | 2019 | 217 | |
| 16 | 2016 | 201 | |
| 17 | 2018 | 164 | |
| 18 | Ferric Carboxymaltose in Heart Failure with Iron Deficiency Hit paper breakdown → | 2023 | 157 |
| 19 | 2012 | 157 | |
| 20 | Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial Hit paper breakdown → | 2022 | 157 |
About Robert John Mentz
Robert John Mentz is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Family Practice and Surgery, having authored 682 papers that have together received 23.4k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (301 papers), Cardiovascular Function and Risk Factors (113 papers), Diabetes Treatment and Management (63 papers), Cardiac pacing and defibrillation studies (52 papers), Mechanical Circulatory Support Devices (39 papers), Potassium and Related Disorders (33 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers) and Electrolyte and hormonal disorders (24 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (11.0k citations), Endocrinology, Diabetes and Metabolism (5.4k citations), Geriatrics and Gerontology (497 citations), Nephrology (698 citations) and Complementary and alternative medicine (645 citations). Robert John Mentz has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Christopher M. O’Connor, Adrian F. Hernandez, Gary Michael Felker, Mona Fiuzat, Stephen John Greene, Adam D DeVore, Aldo Pietro Maggioni, Rury R. Holman, Javed Butler and Gregg Fonarow. Their work appears in journals such as Journal of Cardiac Failure, American Heart Journal, European Journal of Heart Failure, Journal of the American College of Cardiology and JACC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.